It has been brought to our attention that EHS Housing has recently been cold calling our speakers offering accommodation for a named Fusion conference. Please note that we have no association with EHS Housing and they are acting on our behalf without our permission. We strongly advise that any calls from EHS Housing are ignored or ended immediately. If you are contacted by EHS Housing, please notify us immediately.
All Fusion registration fees are inclusive of accommodation (for three fixed nights) and reservations are handled internally, entirely by Fusion Conferences. If you have any questions concerning your accommodation, please contact Fusion Conferences directly via email@example.com.
Fusion Conferences specialise in organising scientific based conferences within the academic and corporate industry for those working at the forefront of physical, medical, life sciences and their related technologies. To find out more, please navigate to our About Us page.
We hope to welcome you to a Fusion conference soon.
|13 Feb 2019||6th Nucleic Acids Conference
Poster Submission: 10 Dec 18
|Register Now for 6th Nucleic Acids Conference|
|15 Feb 2019||3rd Fibroblast Growth Factors in Development and Repair Conference
Talk Submission: 01 Dec 18
|Register Now for 3rd Fibroblast Growth Factors in Development and Repair Conference|
|17 Feb 2019||Epithelial Mesenchymal Interactions in Lung Development and Fibrosis Conference
Last Chance: 03 Dec 18
|Register Now for Epithelial Mesenchymal Interactions in Lung Development and Fibrosis Conference|
|19 Feb 2019||3rd Small Molecule Activation Conference
Last Chance: 05 Dec 18
|Register Now for 3rd Small Molecule Activation Conference|
|21 Feb 2019||4th Drug Discovery Re-Invented Conference
Emerging Role of Biotechs, Academics and Non-Profits
Early Bird: 03 Dec 18
|Register Now for 4th Drug Discovery Re-Invented Conference|
|23 Feb 2019||3rd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference
Last Chance: 12 Dec 18
|Register Now for 3rd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference|